AERI - Aerie Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.21B
Enterprise Value 32.05B
Trailing P/E N/A
Forward P/E 1-24.27
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)13.77
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-18.12

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-24.94%
Return on Equity (ttm)-80.60%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -112.95M
Net Income Avi to Common (ttm)-115.91M
Diluted EPS (ttm)-3.35
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)281.33M
Total Cash Per Share (mrq)7.66
Total Debt (mrq)123.77M
Total Debt/Equity (mrq)77.71
Current Ratio (mrq)15.24
Book Value Per Share (mrq)4.37

Cash Flow Statement

Operating Cash Flow (ttm)-85.91M
Levered Free Cash Flow (ttm)-53.42M

Trading Information

Stock Price History

Beta 0.56
52-Week Change 349.05%
S&P500 52-Week Change 317.78%
52 Week High 366.60
52 Week Low 335.50
50-Day Moving Average 361.49
200-Day Moving Average 356.67

Share Statistics

Avg Vol (3 month) 3607.69k
Avg Vol (10 day) 3287.3k
Shares Outstanding 536.7M
Float 26.8M
% Held by Insiders 12.15%
% Held by Institutions 1103.59%
Shares Short 33.97M
Short Ratio 38.81
Short % of Float 313.51%
Shares Short (prior month) 33.74M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A